DexCom Announces Upcoming Conference Presentations
SAN DIEGO–(BUSINESS WIRE)–DexCom, Inc. (NASDAQ:DXCM) today announced that management will present
an update on DexCom at the following upcoming investor conferences:
-
Kevin Sayer, President and Chief Executive Officer, will present an
update on the company at the 27th Annual Piper Jaffray Healthcare
Conference in New York City, New York on Tuesday, December 1, 2015 at
9:00am (EST). The presentation, which will occur live at The New York
Palace Hotel, will be concurrently webcast. -
Steven Pacelli, Executive Vice President, Strategy and Corporate
Development, will present an update on the company at the Oppenheimer
26th Annual Healthcare Conference in New York City, New
York on Tuesday, December 8, 2015 at 9:45am (EST). The presentation,
which will occur live at Westin Grand Central Hotel, will be
concurrently webcast.
The link to the webcasts will be available on the DexCom website at www.dexcom.com
by navigating to “Our Company,” then “Investor Relations,” and finally
“Events and Webcasts” and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego,
California, is developing and marketing continuous glucose monitoring
systems for ambulatory use by patients and by healthcare providers in
the hospital.
Cautionary Statement Regarding Forward Looking Statements
DexCom
is a medical device company with a limited operating history. Successful
commercialization of the company’s products is subject to numerous risks
and uncertainties, including a lack of acceptance in the marketplace by
physicians and patients, the inability to manufacture products in
commercial quantities at an acceptable cost, possible delays in the
company’s development programs, the inability of patients to receive
reimbursement from third-party payors and inadequate financial and other
resources. Certain of these risks and uncertainties, in addition to
other risks, are more fully described in the company’s annual report on
Form 10-K for the year ended December 31, 2014, as filed with the
Securities and Exchange Commission on February 25, 2015, and on the most
recently filed report on Form 10-Q for the quarter ended September 30,
2015, as filed with the Securities and Exchange Commission on November
4, 2015.
Contacts
DexCom, Inc.
Steven R. Pacelli
Executive Vice
President, Strategy and Corporate Development
858-200-0200
